Use cautionDrug recall · FDA · Published April 3, 2013
Boehringer Ingelheim Recalls Oxcarbazepine Oral Suspension Due to Resuspension Issues
Boehringer Ingelheim recalls one lot of Oxcarbazepine Oral Suspension because it did not meet resuspendability requirements. Check your bottle's lot number.
Boehringer Ingelheim Roxane Inc is recalling a specific lot of Oxcarbazepine Oral Suspension, 300 mg/5 mL, in 250 mL bottles. The recall was issued because the product did not meet resuspendability requirements, meaning the medication may not mix properly. This could affect the dosage accuracy for patients taking this prescription drug. Read more at govinfonow.com/recall/48152-boehringer-ingelheim-roxane-inc-recalls-oxcarbazepine-oral-suspension-300-mg.
“Boehringer Ingelheim Recalls Oxcarbazepine Oral Suspension Due to Resuspension Issues.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48152-boehringer-ingelheim-roxane-inc-recalls-oxcarbazepine-oral-suspension-300-mg. Based on FDA recall #D-002-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-002-2014%22&limit=1).
The FDA announced on April 3, 2013, that Boehringer Ingelheim Roxane Inc voluntarily recalled Oxcarbazepine Oral Suspension due to resuspension problems. The Class II recall affects 10,267 bottles distributed nationwide.
How to tell if you have it
Brand: Boehringer Ingelheim Roxane
Product: Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle
NDC: 0054-0199-59
Lot #: 161304B
Expiration: OCT 2013
The hazard
The recalled lot did not meet resuspension requirements, according to the FDA. The agency classified this as a Class II recall.
Context
GovInfoNow's records show Boehringer Ingelheim Roxane Inc has had 12 other recalls since November 5, 2012. Other recent recalls of similar products include FUROSEMIDE Tablets USP (September 25, 2015), Combivent Respimat (July 24, 2015), and Acarbose 50mg Tablets (April 2, 2015).
How to tell if you have this one
Check your bottle for NDC 0054-0199-59 and Lot # 161304B. The expiration date on the bottle is OCT 2013. The product is a prescription-only oral suspension in a 250 mL bottle.
Brand
Boehringer Ingelheim Roxane
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Bottle
Verify if your Oxcarbazepine Oral Suspension bottle has NDC 0054-0199-59 and Lot # 161304B.
Contact Your Pharmacist
If you have the recalled lot, contact your pharmacist or healthcare provider for instructions on replacement or disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 10 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-002-2014 (April 3, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-002-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.